Association of Mycoplasma pneumoniae coinfection with adenovirus pneumonia severity in children

Main Article Content

Jinfeng Wei
Suling Wu
Xuefeng Jin
Jie Zhang
Shanshan Pan


Adenovirus pneumonia, coinfection, children, Mycoplasma pneumoniae


Between the winter of 2018 and the end of 2019, there has been an epidemic of adenovirus infection in southern China, including Zhejiang Province. The number of children suffering from adenovirus pneumonia (AP) has significantly increased. AP can be accompanied by Mycoplasma pneumoniae in children. This study aimed to investigate the association of M. pneumoniae and identify the risk factors for coinfection on hospitalized patients with AP. The patients were classified into two groups by etiologic analysis (single AP and AP with M. pneumoniae coinfection groups). The clinical manifestations, clinical medication, and laboratory and imaging findings of the two groups were compared and analyzed. The coinfection group (n = 125) had a significantly longer duration of fever than the single AP group (n = 171; P = 0.03). Shortness of breath (P = 0.023) and pulmonary imaging findings, such as pulmonary consolidation, atelectasis, pleural effusion, and multilobe lesions (P < 0.05), were more common in the coinfection group. The patients with coinfection had more severe symptoms, significantly longer hospitalization time and an increased proportion of using glucocorticoids and/or immunoglobulin needing oxygen inhalation (P < 0.05). The incidence of AP with M. pneumoniae coinfection is high. The prolonged fever duration and pulmonary imaging findings could be used as prediction factors to predict M. pneumoniae coinfection in children with AP. Patients with AP coinfected with MP may easily develop severe illness. Hence, a reasonable change in the treatment is necessary.

Abstract 58 | PDF Downloads 26 HTML Downloads 5 XML Downloads 1


1. Le Roux DM, Zar HJ. Community-acquired pneumonia in children—a changing spectrum of disease. Pediatr Radiol. 2017;47(11):1392–8. 10.1007/s00247-017-3827-8

2. Nascimento-Carvalho CM. Community-acquired pneumonia among children: the latest evidence for an updated management. J Pediatr. 2020;96:29–38. 10.1016/j.jpedp.2019.08.002

3. Yun KW, Wallihan R, Juergensen A, Mejias A, Ramilo O. Community-acquired pneumonia in children: myths and facts. Am J Perinatol. 2019;36(S 02):S54–7. 10.1055/s-0039-1691801

4. Jobran S, Kattan R, Shamaa J, Marzouqa H, Hindiyeh M. Adenovirus respiratory tract infections in infants: a retrospective chart-review study. Lancet. 2018;391:S43. 10.1016/S0140-6736(18)30409-4

5. Zaifang J, Chen W, Quan L, Yiji H, Zongqi D, Xin N, et al. Standards for diagnosis and treatment of adenovirus pneumonia in children (2019 edition). Chinese J. Infect Dis. 2019:3:161–6. Chinese. 10.26549/yzlcyxzz.v3i5.4992

6. Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747–809. 10.1128/CMR.00114-16

7. Zhou Y, Wang J, Chen W, Shen N, Tao Y, Zhao R, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC infect dis. 2020;20(1):633. 10.1186/s12879-020-05356-1

8. La Fay C, Bosdure E, Baravalle-Einaudi M, Stremler-Le Bel N, Dubus J-C, Mazenq J. Severe adenovirus pneumonia with hemophagocytic syndrome and respiratory failure. Arch Pediatr. 2020;27(7):383–5. 10.1016/j.arcped.2020.07.003

9. Lim LM, Woo YY, De Bruyne JA, Nathan AM, Kee SY, Chan YF, et al. Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia. PLoS ONE. 2018;13(10):e0205795. 10.1371/journal.pone.0205795

10. Xie L, Zhang B, Xiao N, Zhang F, Zhao X, Liu Q, et al. Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China. J Med Virol. 2019;91(3):392–400. 10.1002/jmv.25333

11. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372(9):835–45. 10.1056/NEJMoa1405870

12. Bakir J, Juárez MdV, Lución MF, Areso MS, Viegas M, Mistchenko AS, et al. Clinical and epidemiological study of acute lower respiratory tract infections caused by adenovirus in hospitalized children. Nineteen years of active epidemiological surveillance. Arch Argent Pediatr. 2020;118(3):193–201. 10.5546/aap.2020.eng.193

13. Yao L-h, Wang C, Wei T-l, Wang H, Ma F-l, Zheng L-S. Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017–2018. Virol J. 2019;16(1):1–8. 10.1186/s12985-019-1185-x

14. Jiang W, Wu M, Zhou J, Wang Y, Hao C, Ji W, et al. Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia. BMC Infect Dis. 2017;17(1):1–8. 10.1186/s12879-017-2891-x

15. Siew JX, Seah XFV, Chew YR, Thoon KC, Chong CY, Yung CF, et al. Epidemiology of adenovirus infections and outcomes of cidofovir treatment in severely Ill children. J Pediatr Infect Dis. 2020;39(10):907–13. 10.1097/INF.0000000000002726

16. Liu C, Xiao Y, Zhang J, Ren L, Li J, Xie Z, et al. Adenovirus infection in children with acute lower respiratory tract infections in Beijing, China, 2007 to 2012. BMC Infect Dis. 2015;15(1):1–9. 10.1186/s12879-015-1126-2

17. Hage E, Huzly D, Ganzenmueller T, Beck R, Schulz TF, Heim A. A human adenovirus species B subtype 21a associated with severe pneumonia. J Infect. 2014;69(5):490–9. 10.1016/j.jinf.2014.06.015

18. Zhou Y, Wang J, Chen W, Shen N, Tao Y, Zhao R, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20(1):1–10. 10.1186/s12879-020-05356-1